Life in the RAS Lane: Frank McCormick and the Pursuit of Pancreatic Cancer’s Driver
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
Tag: Pancreatic cancer
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Understanding pancreatic cancer’s strengths may provide clues to its weaknesses.
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
In the opening keynote session of the AACR Special Conference on Pancreatic Cancer, which took place September 27-30 in...